GL1X · GenesisL1 explorer

Research workbench

Crystal structure of clostridium botulinum neurotoxin type E catalytic domain

Analyse Crystal structure of clostridium botulinum neurotoxin type E catalytic domain in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1T3A
Type
protein
Length
798 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neurotoxin type E
EC
3.4.24.69
UniProt
Q00496
Ligands
ZN, CL
Pockets
8 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeurotoxin type E (EC 3.4.24.69)protein40035% helix, 18% strandQ00496
BNeurotoxin type E (EC 3.4.24.69)protein39836% helix, 18% strandQ00496

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19710.810.83100empty
22330.570.7938ZN
32370.550.7839empty
4840.370.7623empty
5990.350.7422empty

Interfaces

1 interface between chains.

  • A–B · 1290 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 1T3A · Crystal structure of Clostridium botulinum neurotoxin type E catalytic domain · the same entry in another collection · chain B against B, TM-score 1.00
  • Q00496 · AlphaFold monomer V2.0 prediction for botulinum neurotoxin type E (Q00496) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.